Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BILISAN Leberkomplex-Repha is a dietary supplement (Nahrungsergänzungsmittel) developed by Repha GmbH Biologische Arzneimittel, specifically formulated to support and maintain normal liver function. The product contains a combination of three active components: milk thistle fruit extract (97.5 mg), turmeric root extract (52.5 mg), and choline hydrogen tartrate. Choline is an essential nutrient that contributes to normal lipid metabolism and the maintenance of liver function. Milk thistle (Silybum marianum) is included for its hepatoprotective properties, helping to protect liver cells and maintain overall liver health. Turmeric (Curcuma longa) supports digestive function by promoting healthy bile flow. The supplement is administered orally in the form of hard capsules.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on BILISAN Leberkomplex-Repha.